Filing Details

Accession Number:
0001209191-15-070350
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-11 16:53:46
Reporting Period:
2015-08-19
Filing Date:
2015-09-11
Accepted Time:
2015-09-11 16:53:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1567514 Intra-Cellular Therapies Inc. ITCI Pharmaceutical Preparations (2834) 364742850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1585666 A. Allen Fienberg C/O Intra-Cellular Therapies, Inc.
430 East 29Th Street
New York NY 10016
Vp Of Business Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-09-09 12,500 $1.36 295,000 No 4 M Direct
Common Stock Disposition 2015-08-19 10,000 $30.30 198,023 No 4 S Indirect Held by J.D.F. Holdings Ltd.
Common Stock Disposition 2015-08-21 200 $30.30 197,823 No 4 S Indirect Held by J.D.F. Holdings Ltd.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Indirect Held by J.D.F. Holdings Ltd.
No 4 S Indirect Held by J.D.F. Holdings Ltd.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-09-09 12,500 $0.00 12,500 $1.36
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2006-12-05 No 4 M Direct
Footnotes
  1. Dr. Fienberg holds a 20% ownership interest in J.D.F. Holdings Ltd. and may be deemed to beneficially own the securities held by J.D.F. Holdings Ltd. Dr. Fienberg disclaims beneficial ownership of the securities held by J.D.F. Holdings Ltd. except to the extent of his pecuniary interest therein.
  2. All shares underlying this option have vested.